NCT01584830 - Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy | Biotech Hunter

Enrollment

204

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

January 31, 2016

Conditions

Colorectal Neoplasms

Interventions

DRUG

Regorafenib (BAY73-4506)

Regorafenib BAY73-4506 will be given 3 weeks on/1 week off (160 mg od po.)

DRUG

Placebo

Placebo will be given 3 weeks on/1 week off (160 mg od po.)

Trial Locations (25)

84

Ho Chi Minh City

333

Taoyuan District

10016

Taipei

11217

Taipei

100021

Beijing

100071

Beijing

100142

Beijing

130021

Changchun

150056

Harbin

200030

Shanghai

200032

Shanghai

200080

Shanghai

210002

Nanjing

266003

Qingdao

300060

Tianjin

310016

Hangzhou

510060

Guangzhou

510080

Guangzhou

610041

Chengdu

710032

Xi'an

Unknown

Shatin

Hong Kong

Hanoi

Ho Chi Minh City

138-736

Seoul